Abstract
Human papillomavirus (HPV) research and vaccination programs are built upon layered presumptions rather than direct measurement. At the center of this narrative lies the assumption that microabrasions—microscopic epithelial disruptions—are both universal and inevitable. Yet, if microabrasions do not occur, HPV cannot establish infection. This makes microabrasions the most vital part of the fight against HPV, while simultaneously the least quantified. The absence of population‑level data on microabrasion prevalence renders all subsequent claims about infection and disease progression presumptive. This article, the fourth in the series on the HPV Vaccines Biological Impossibilities (HVBI) Theory by Praveen Dalal, expands the discussion with deeper analysis of presumption, showing how the entire HPV science collapses into pseudoscience when examined critically. It integrates prior analyses on screening and treatment, immune system dynamics, and vaccine inefficacy, and proposes individual and population‑level strategies to reduce HPV risk by addressing microabrasions directly.
Introduction
HPV is widely described as the most common sexually transmitted infection, with claims that nearly all sexually active individuals will acquire it during their lifetime. Central to this narrative is the role of microabrasions—microscopic epithelial disruptions that allow viral access to basal cells. While laboratory and clinical studies have documented microabrasions, their prevalence in the general population remains unmeasured. Epidemiological studies extrapolate from limited samples to assert near‑universal infection, and clinical outcomes are often treated as proof of universality. This review interrogates these claims, exposing the presumptions that underpin HPV science and situating them within the broader HVBI Theory.
Screening And Treatment Discredited
As discussed in The Mysterious Disappearance of HPV Screening and Treatment Post‑2006, the vaccine lobby systematically sidelined screening and treatment strategies once HPV vaccines were introduced. Screening methods such as Pap smears and HPV DNA testing had proven effective in detecting precancerous lesions, while treatment protocols addressed progression to disease. Yet these were marginalized in favor of vaccination campaigns, despite the fact that vaccines do not prevent infection itself.
This discrediting of screening and treatment reflects the broader problem of presumption in HPV science. By assuming universality of infection and inevitability of disease, public health narratives shifted focus away from proven interventions toward speculative and unscientific measures like HPV vaccines. The result is a system that prioritizes vaccination while neglecting the very tools that could directly reduce morbidity and mortality.
Immune System Dynamics
The HVBI Theory also highlights the complexity of immune responses to HPV, as detailed in HPV‑16 and HPV‑18 Immune System Dynamics, Vaccination and Population‑Level Outcomes. Natural infections often resolve spontaneously due to immune clearance, with only a minority progressing to persistent disease. Vaccination, however, attempts to mimic immunity artificially, yet is biologically incapable to replicate the nuanced dynamics of natural clearance.
This disconnect underscores the presumptive nature of HPV science. By assuming that vaccination can substitute for natural immune processes, researchers and policymakers ignore the variability of immune responses across populations. The claim of universal protection collapses when confronted with the reality that most infections resolve without intervention, and that vaccines cannot prevent initial infection if microabrasions provide viral entry.
The discussion on immune system dynamics reinforces the centrality of the immune system in HPV clearance. It demonstrates that more than 95% of infections are naturally resolved within one to two years, with persistence and progression to cancer occurring only in rare cases of immune weakness. Vaccines, while useful in raising alarms, do not alter these timelines. They cannot prevent persistence in immunocompromised individuals, nor can they address infections from non‑covered strains.
At the population level, vaccines are credited with reducing cervical cancer incidence, but this attribution is misleading. The analysis argues that clearance is immune-driven, and vaccines merely accelerate recognition of certain strains. Messaging that credits vaccines with “saving lives” obscures the immune system’s decisive role and risks overstating vaccine efficacy. The article calls for a reframing of public health narratives to acknowledge vaccines as alarms, while situating clearance and protection within the broader context of immune strength and screening programs.
Why HPV Vaccines Do Not Prevent Infection
The HVBI Theory further argues, as shown in HPV‑16 and HPV‑18: Why HPV Vaccines Do Not Prevent HPV Infections, that HPV‑16 and HPV‑18 infections are overwhelmingly cleared by the immune system, not vaccines. Vaccines do not prevent infections; they serve as alarms that expose stealth oncogenic strains to immune recognition. The immune system clears infections, and screening plus treatment protect those for whom clearance fails. A more precise narrative would acknowledge vaccines as signals, while the immune system remains the final arbiter of outcome.
The HVBI Theory calls for a reframing of public health narratives: HPV vaccines must be contextualized as just limited alarm tools for strains covered, within a broader immune and epidemiological framework, not glorified as independent saviors.
Also, vaccines cannot prevent infection at the mechanistic level. Since HPV requires microabrasions for entry, and vaccines do not alter the occurrence of microabrasions, infection would occur regardless of vaccination status. Ironically, vaccines have nil influence over immune response post‑infection and since they cannot block the initial event, HPV vaccines are 100% useless even if we ignore their severe side effects.
This makes the presumption of vaccine‑based prevention scientifically untenable. If microabrasions are unquantified, and vaccines cannot prevent their occurrence and HPV infection from taking place, then claims of infection prevention rest entirely on assumptions. The narrative of vaccine efficacy thus collapses into pseudoscience when examined through the lens of mechanistic reality.
If There Are No Microabrasions, There Is No HPV Infection
The most vital truth in HPV science is that without microabrasions, infection cannot occur. This makes microabrasions the absolute prerequisite for HPV transmission. Yet their prevalence is unknown, leaving the entire infection narrative built on presumption. If microabrasions occur in only 10% of sexual encounters, then infection prevalence would logically align with that figure. If they occur in 20%, infection prevalence would rise accordingly. Without direct measurement, every claim about HPV prevalence is contingent on an unverified assumption about microabrasion frequency.
Therefore, the fight against HPV must begin with microabrasions. If they are rare, infection risk is proportionally rare. If they are common, infection risk is proportionally common. But until their prevalence is measured, all claims remain presumptive. This makes microabrasions not only the biological gateway for HPV but also the epistemological gateway for understanding the infection itself. Without clarity on microabrasions, HPV science cannot claim certainty.
Proposed Solutions To Prevent HPV Entry Via Microabrasions
If microabrasions are the critical gateway for HPV infection, then preventing viral particles from reaching these disruptions becomes the most rational line of defense. Unlike vaccines, screening, or treatment—which operate downstream—these strategies focus on individual and population‑level actions that reduce the likelihood of viral entry at the very first stage.
(1) Medical Measures: Barrier protection (condoms, dental dams) reduces mucosal contact; lubrication lowers friction and microabrasion formation; experimental topical microbicides may provide chemical barriers; and maintaining genital health reduces epithelial fragility.
(2) Non‑Medical Measures: Safe sexual practices (avoiding high‑friction activity, ensuring adequate arousal), gentle hygiene practices, nutrition supporting epithelial resilience, public education on lubrication and barrier use, and discouragement of harmful cultural practices (e.g., dry sex) all reduce microabrasion risk.
These strategies highlight that HPV prevention does not have to rely solely on downstream interventions. By focusing on mucosal integrity and barrier protection, individuals and populations can reduce the likelihood of viral entry at the mechanistic level. Importantly, these measures do not assume universality of microabrasions; instead, they acknowledge variability and aim to minimize their occurrence and impact.
Conclusion
HPV infection science, as currently communicated, rests on layered presumptions rather than direct measurement. The most vital truth is that without microabrasions, there is no HPV infection. Yet their prevalence is unmeasured, making all infection claims contingent on assumption. If microabrasions occur in 10% of encounters, infection prevalence would mirror that; if 20%, infection prevalence would rise accordingly. Without quantification, universality claims collapse into presumption.
The HVBI Theory, as articulated by Praveen Dalal, exposes these biological impossibilities by showing how screening and treatment were discredited, how immune system dynamics were gaslighted, and why vaccines cannot prevent infection. A more rigorous scientific position would separate mechanism, prevalence, and outcomes, acknowledge the gaps, and resist oversimplification. Furthermore, practical solutions exist to reduce HPV risk at the earliest stage of infection by preventing viral access to microabrasions. Integrating these strategies into public health discourse would provide a more balanced, evidence‑based framework, moving HPV science away from presumption and toward genuine prevention.